Clinical Trials Browser

Phase 2 × Terminated × Febrile Neutropenia × Clear all

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Phase 2 Terminated

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Phase 2 Terminated

2 enrolled 2 charts

Classical hematology

Neoplasms, Febrile Neutropenia